Read More Pharma Industry News Orphan Technologies starts OT-58 trial for homocystinuria treatment breakthrough Swiss pharmaceutical company Orphan Technologies has begun dosing patients in a Phase 1/2 trial (CBS-HCY-01) to assess the… bypharmanewsdailyFebruary 16, 2019